Baxevanis, Constantin N <br/><br/>
HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes.  [electronic resource] 

 -  International journal of cancer  Apr 2002 
 - 864-72 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/ijc.10251  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--immunology<br/>Antibodies, Monoclonal--immunology<br/>CD3 Complex--immunology<br/>CD56 Antigen--immunology<br/>Cytotoxicity Tests, Immunologic<br/>Epitopes--immunology<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Immunotherapy<br/>Killer Cells, Natural--immunology<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Monocytes--immunology<br/>Ovarian Neoplasms--immunology<br/>Receptor, ErbB-2--immunology<br/>Receptors, Antigen, T-Cell, alpha-beta--metabolism<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Transfection<br/>Tumor Cells, Cultured